SGLT2 inhibitors as the bedrock of therapy for heart failure.
Publication Title
Lancet
Document Type
Article
Publication Date
9-3-2022
Keywords
washington; spokane; pmrc; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors
Area of Special Interest
Kidney & Diabetes
Area of Special Interest
Cardiovascular (Heart)
Specialty/Research Institute
Cardiology
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Nephrology
COinS
